Skip to main content

Table 6 Summary of Adverse Events in Patients Receiving Ranibizumab

From: Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab

Ocular Adverse Events (E = 8)

Non-ocular Adverse Events (E = 5)

Angle Closure Glaucoma

1

Neck Pain

1

Cataract

1

Dizziness

1

Pigment Dispersion Syndrome

1

Hemorrhagic Stroke

1

Vitreous Hemorrhage

1

Headache

1

III Nerve Paralysis

1

Dog Bite

1

Intraocular Pressure Increased

2

  

Neovascularization

1

  
  1. n = 8; n Number of patients with adverse events; E Number of events
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us